Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Johnson and Johnson
Fish and Richardson
Cantor Fitzgerald

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,035,021

« Back to Dashboard

Title:Somatostatin analogues
Abstract: The invention provides cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O--)Pro}-Phg-DTrp-Lys-Tyr(4-B- enzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
Inventor(s): Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bodmer; David (Klingnau, CH), Bruns; Christian (Freiburg, DE), Felner; Ivo (Reinach, CH), Hellstern; Heribert (Heitersheim, DE), Lewis; Ian (Riehen, CH), Meisenbach; Mark (Durmenach, FR), Weckbecker; Gisbert (Biel-Benken, CH), Wietfeld; Bernhard (Efringen-Kirschen, DE)
Assignee: Novartis AG (Basel, CH)
Filing Date:Mar 16, 2011
Application Number:13/048,935
Claims:1. A process for the production of a compound of formula ##STR00002## or a salt thereof, comprising cyclising a linear peptide selected from the group consisting of DTrp-Lys-Xa1-Phe-Xa2-Xa3, Xa3-DTrp-Lys-Xa1-Phe-Xa2, Xa2-Xa3-DTrp-Lys-Xa1-Phe, Phe-Xa2-Xa3-DTrp-Lys-Xa1, Xa1-Phe-Xa2-Xa3-DTrp-Lys, and Lys-Xa1-Phe-Xa2-Xa3-Trp, wherein Xa1 represents O-benzyl-tyrosine, Xa2 represents 2-carboxy-4-(2-aminoethyl-carbonyloxyamino)pyrrolidine, and Xa3 represents phenylglycine, respectively, in protected form or in protected and polymer bound form and removing the protecting group(s) or cleaving from the polymer and removing the protecting group(s), in such a way to obtain said compound, and recovering said compound in free or salt form.

2. The process according to claim 1, wherein said cyclizing of said linear peptide produces a bond between the carboxyl group of O-benzyl-tyrosine and the amino group of Phe.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.